INVESTOR ALERT: Fields Kupka & Shukurov LLP Is Investigating Akebia Therapeutics, Inc. for Potential Breach of Fiduciary Duty Claims.

NEW YORK, April 10, 2020 (GLOBE NEWSWIRE) -- Fields Kupka & Shukurov LLP is investigating potential breach of fiduciary duty claims involving the board of directors of Akebia Therapeutics, Inc. (NASDAQ: AKBA).

If you are a shareholder of Akebia Therapeutics, Inc. and wish to receive additional information, free of charge, please visit us at:

https://fksfirm.com/investigation-akebia-therapeutics-inc-akba/

or contact William J. Fields, via email at wfields@fksfirm.com or by phone at (212) 231-1500. We will speak with you at no cost or obligation to you.

Fields Kupka & Shukurov LLP is a law firm which represents victims of securities fraud, breaches of fiduciary duty, or other corporate misconduct. For more information about us, please visit our website at www.fksfirm.com. Attorney Advertising. Prior results do not guarantee a similar outcome.

Fields Kupka & Shukurov LLP
William J. Fields
1370 Broadway
5th Floor – #5100
New York, NY 10018
Tel: (212) 231-1500
Fax: (646) 851-0076
www.fksfirm.com

Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.